ADR.AU · Adherium Limited

-

Please sign in to comment on ADR.AU

1 Comment

Admin

4 years, 1 month ago

Adherium Limited is currently in a long term downtrend where the price is trading 21.1% below its 200 day moving average.

From a valuation standpoint, the stock is 96.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.5.

Adherium Limited's total revenue sank by 82.2% to $253K since the same quarter in the previous year.

Its net income has dropped by 91.5% to $-9M since the same quarter in the previous year.

Finally, its free cash flow fell by 75.7% to $-3M since the same quarter in the previous year.

Based on the above factors, Adherium Limited gets an overall score of 1/5.

Sector
Industry
Exchange	AU
CurrencyCode	AUD
ISIN	AU000000ADR1

Beta	2.21
Market Cap	3M
PE Ratio	None
Target Price	0.0789
Dividend Yield	None

ABOUT

Adherium Limited

Adherium Limited develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. The company offers Hailie Smartinhaler, an asthma and chronic obstructive pulmonary disease medication adherence solution for patients with chronic respiratory diseases. It also provides Bluetooth enabled Hailie sensors, which wrap around patient inhalers and offers real-time feedback to patients; Hailie app; and Hailie portal, as well as Hailie remote patient management solution. The company was founded in 2001 and is based in Melbourne, Australia.

ADR.AU · Adherium Limited

-

Adherium Limited

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Adherium Limited using a moving average strategy